Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 4
2019 5
2020 2
2021 1
2022 2
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding: the UCON randomised controlled trial and mechanism of action study.
Whitaker LHR, Middleton LJ, Priest L, Odedra S, Cheed V, Nicholls EP, Williams ARW, Roberts N, Stubbs CE, Tryposkiadis K, Bensoussane H, Chodankar R, Murray AA, Nicol M, Tsolova AO, Yin K, Cruz M, Leow HW, Kershaw LE, McLenachan SL, McKillop G, Walker J, Semple SI, Clark TJ, Lumsden MA, Hapangama DK, Saraswat L, Bhattacharya S, Smith P, Daniels J, Critchley HOD. Whitaker LHR, et al. Among authors: williams arw. Southampton (UK): National Institute for Health and Care Research; 2023 Oct. Southampton (UK): National Institute for Health and Care Research; 2023 Oct. PMID: 37931048 Free Books & Documents. Review.
Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial.
Whitaker LHR, Middleton LJ, Daniels JP, Williams ARW, Priest L, Odedra S, Cheed V, Stubbs CE, Clark TJ, Lumsden MA, Hapangama DK, Bhattacharya S, Smith PP, Nicholls EP, Roberts N, Semple SI, Saraswat L, Walker J, Chodankar RR, Critchley HOD; UCON Collaborative. Whitaker LHR, et al. Among authors: williams arw. EClinicalMedicine. 2023 May 18;60:101995. doi: 10.1016/j.eclinm.2023.101995. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37251622 Free PMC article.
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.
Hollis RL, Meynert AM, Michie CO, Rye T, Churchman M, Hallas-Potts A, Croy I, McCluggage WG, Williams ARW, Bartos C, Iida Y, Okamoto A, Dougherty B, Barrett JC, March R, Matakidou A, Roxburgh P, Semple CA, Harkin DP, Kennedy R, Herrington CS, Gourley C. Hollis RL, et al. Among authors: williams arw. Clin Cancer Res. 2022 Aug 15;28(16):3546-3556. doi: 10.1158/1078-0432.CCR-22-0368. Clin Cancer Res. 2022. PMID: 35696721 Free PMC article.
Effects of the levonorgestrel intrauterine system on the endometrium after long-term exposure to mifepristone: Secondary outcomes of a randomized controlled trial.
Papaikonomou K, Frisendahl C, Williams ARW, Gemzell-Danielsson K. Papaikonomou K, et al. Among authors: williams arw. Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:330-335. doi: 10.1016/j.ejogrb.2020.06.056. Epub 2020 Jun 26. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32653606 Clinical Trial.
Physiology of the Endometrium and Regulation of Menstruation.
Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Critchley HOD, et al. Among authors: williams arw. Physiol Rev. 2020 Jul 1;100(3):1149-1179. doi: 10.1152/physrev.00031.2019. Epub 2020 Feb 7. Physiol Rev. 2020. PMID: 32031903 Free article. Review.
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
Hollis RL, Churchman M, Michie CO, Rye T, Knight L, McCavigan A, Perren T, Williams ARW, McCluggage WG, Kaplan RS, Jayson GC, Oza A, Harkin DP, Herrington CS, Kennedy R, Gourley C. Hollis RL, et al. Among authors: williams arw. Cancer. 2019 Aug 15;125(16):2772-2781. doi: 10.1002/cncr.32079. Epub 2019 Jun 2. Cancer. 2019. PMID: 31154673 Free PMC article.
Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA, Diamond MP, Williams ARW, Carr BR, Myers ER, Feldman RA, Elger W, Mattia-Goldberg C, Schwefel BM, Chwalisz K. Stewart EA, et al. Among authors: williams arw. Hum Reprod. 2019 Apr 1;34(4):623-634. doi: 10.1093/humrep/dez007. Hum Reprod. 2019. PMID: 30865281 Free PMC article. Clinical Trial.
16 results